Using two-dimensional echocardiography, pulmonary vascular resistance was estimated from right ventricular pre-ejection period to ejection time (RVPEP/ET) in 11 preterm infants with respiratory distress, to test the effect of different doses of continuous lipid infusion. Echocardiography was performed at baseline with no lipid infusing 2 and 24 hours after 1*5 and 3 g/kg/day of intravenous lipid, 24 hours after discontinuing intravenous lipid emulsion, and 2 hours after restarting intravenous lipid. After 24 hours of intravenous lipid at 1 5 g/kg/day the RVPEP/ET rose to mean (SD) 0*287 (0.03) from a baseline value of 0*225 (0.02) and to 0*326 (0.05) after 24 hours ofintravenous lipid at 3 g/kg/day. Pulmonary arterial pressure returned to baseline 24 hours after the intravenous lipid had been discontinued. Continuous 24 hour infusion of lipid caused significant dose and time-dependent increases in pulmonary vascular resistance. Intravenous lipid may aggravate pulmonary hypertension. (Arch Dis Child 1996; 74: F95-F98) Keywords: total parenteral nutrition, lipid emulsion, pulmonary vascular resistance, echocardiography, respiratory distress.
The use of intravenous lipid emulsions as part of total parenteral nutrition (TPN) is standard practice in the care of preterm infants. In many newborn and adult species the short term and long term complications associated with intravenous lipid emulsions include decreased arterial oxygen tensions' and pulmonary diffusing capacity,2 increased pulmonary vasomotor tone, and arterial pressure. [3] [4] [5] [6] In the human neonate there have been reports of histological evidence of pulmonary hypertension and pulmonary arterial lipid deposit7-9; and chronic lung disease.10 11 The alteration in the pulmonary vasomotor tone caused by intravenous lipid may be mediated by alterations in eicosanoid metabolism.10-'14 In lambs intravenous soybean oil emulsions cause an acute dose-dependent increase in pulmonary arterial pressure, a modest decrease in arterial oxygen tension, and a significant increase in thromboxane A2.12 In low birthweight (LBW) infants without respiratory distress pulmonary arterial diastolic pressure (PADP), as estimated from the right ventricular pre-ejection period over ejection time (RVPEP/ET), increased during the infusion of 02-09 g/kg of intravenous lipid over 2 hours'5 which is equivalent to 2-4-10-8 g/kg/day. Not only is this dose higher than the recommended amount of intravenous lipid -up to 3 g/kg/day16 -but it is also well known that clearance of lipid particles is a function of the amount of emulsion administered over a given time.17 PADP estimates have not been reported in infants with respiratory distress and receiving 24 hour lipid infusions as part of TPN rather than as short term high dose infusions.
The objective of this study was to investigate the effect of different doses of intravenous lipid within the range of current practice for TPN and administered as a continuous infusion, on the pulmonary vascular resistance of LBW infants with different degrees of neonatal respiratory distress, as estimated from RVPEP/ET using two-dimensional and Doppler echocardiography. We hypothesised: (1) avoided by checking to see that the serum triglycerides were below 1 mmol/l,17 18 24 hours after any change in lipid infusion rate.
Seven two-dimensional echocardiograms were performed in the following sequence: (1) before intravenous lipid infusion on the second day of life;. (2) 2 hours after initiation of 0-0625 g/kg/hour (1-5 g/kg/day) of intravenous lipid infusion; (3) 24 hours after starting 00625 g/kg/hour (1.5 g/kg/day) of intravenous infusion on the third day of life; (4) 2 hours after increasing to O 125 g/kg/hour (3 g/kg/day) of intravenous lipid infusion on the third day of life; (5) 24 hours after increasing to 0d125 glkg/hour (3 g/kg/day) of intravenous lipid infusion on the fourth day of life; (6) 24 hours after intravenous lipid was discontinued on the fifth day of life; and (7) 2 hours after 00625 g/kg/hour (1.5 g/kg/day) of intravenous lipid had been restarted.
The echocardiograms were done using an Ultramark 4 with a 5 MHz mechanical sector transducer. The investigator reading the echocardiogram was blinded to the treatment status; intra-observer error was (± 8% of mean (±2 SD). A different investigator who performed the echocardiogram was not blinded to the treatment status. The Doppler flow velocity across the aortic and pulmonary valve and simultaneous ECG were recorded, and the left ventricular pre-ejection period over ejection time (LVPEP/ET) and RVPEP/ET were measured. Six readings were performed for each value to reduce the measurement error. RVPEP/ET was used to estimate PADP echographically because it is independent of heart rate. 19 Pre-ejection periods were measured from onset of the Q wave of a simultaneously recorded ECG tracing to onset of flow. The duration of flow was measured as ejection time. 20 For the ventilated infants, the ventilatory settings were adjusted to maintain the pH between 7'30 and 7 40, the arterial carbon dioxide tension (PaCO2) between 35 and 50 mm Hg. The mean airway pressure was maintained at the same level during the two hour interval between the first and the second echocardiogram on each day, to avoid an effect of changing mean airway pressure on PADP. (table 2) .
To ensure that these findings were not a naturally occurring phenomenon, we performed five serial echocardiograms in each of eight healthy preterm infants who did not have any degree of lung disease and who were not receiving intravenous lipid. There was no significant change in RVPEP/ET or LVPEP/ET values which remained similar for each of the infants. RVPEP/ET values in the control group were 0-256 (002), 0248 (002), 0235 (003), and 0-226 (002) for the first four echocardiograms, and all values were <O*28.
Discussion
The early administration of intravenous lipid emulsions to premature infants has been associated with the development of pulmonary and circulatory complications.1 7-1115 Our data suggest that a continuous 24 hour infusion of intravenous lipid as part of TPN causes a significant dose and time-dependent increase in pulmonary vascular resistance in preterm infants with respiratory distress. By comparison, systemic vascular resistance, as estimated by LVPEP/ET, is unaffected by infusion of lipid. Discontinuing the lipid infusion results in RVPEP/ET values returning to pre-infusion figures. Our findings were consistent in each of the 11 infants.
RVPEP/ET measured by two-dimensional echocardiography is a non-invasive assessment of the pulmonary vascular haemodynamics and a good correlation with PADP has been shown by cardiac catheterisation.19-21 RVPEP/ET is not influenced by either age or heart rate,18 but it is affected by right ventricular preload and function.15 Right ventricular preload, estimated from RVED, did not change during these studies. Each infant in our study served as its own control, and intraventricular conduction was therefore not a source of variance. Consequently, measuring RVPEP/ET serially in the same infant has been considered valuable in detecting trends and changes in PADP.22-24 Although pulmonary arterial pressure can be assessed more accurately by using the Doppler calculated pressure gradient between aorta and main pulmonary artery, only two of the 11 infants studied had a patent ductus arteriosus for the duration of the study. In all infants the velocity profile across the patent ductus arteriosus was left to right by day 2 of age.
Lloyd et al have reported an increase in RVPEP/ET in preterm infants without lung disease when infusing 0-2 to 09 g/kg of lipid over 2 hours.'5 This is equivalent to 2A4-10-8 g/kg of intravenous lipid a day, much higher than the 1 * 5 g and 3 g/kg/day in our study. This large difference in the amount administered might explain why Lloyd et al'5 did, and why we did not, find a significant increase in RVPEP/ET after 2 hours. Whereas 1-5 g and 3 g/kg/day of intravenous lipid may be too low to cause mechanical7 9 or immediate thromboxane-induced pulmonary vasoconstriction, 11 
